Where is Elispot located?

Elispot is headquartered in Shaker Heights, United States.

Where does Elispot rank among its competitors?

Elispot ranks 387th amongst 382 active competitors, of which 42 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abselion, which secured $8.41M in Oct, 2024.

Who are the top competitors of Elispot?

Elispot's top competitors include Siemens Healthineers, Illumina and Quanterix. Among them, Abselion secured the most recent funding round in October, 2024.

Elispot - 2026 Company Profile & Competitors

Company Details

Manufacturer of laboratory assay systems for detecting immune cell responses. These systems utilize enzyme-linked and fluorescent detection methods to quantify cytokine or antibody release from single cells. The technology employs immobilized antibodies on membranes to identify specific immune reactions following antigen stimulation. Analysis hardware enables the enumeration of secreting cells and the differentiation of cell sub-populations based on spectral emission. These tools facilitate the assessment of functional immune status for research and diagnostic applications.

Key Metrics

Location

Shaker Heights, United States

Stage

Unfunded

Ranked

387^th among 431 competitors

Similar Companies

Siemens Healthineers & 429 more

View Elispot's full profile

Elispot has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Elispot include Siemens Healthineers, Illumina and Quanterix. Here is the list of Top 10 competitors of Elispot, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Siemens Healthineers 2017, Forchheim (Germany), Public	Provider of medical imaging laboratory diagnostics and clinical digital solutions	-	Qatar Investment Authority, Skyviews Life Science ... & 3 others	75/100
2nd	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
3rd	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Novalis LifeSciences & 15 others	71/100
4th	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
5th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	Excellere Partners, GHO Capital Partners & 3 others	65/100
6th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 13 others	63/100
7th	Bio-Techne 1981, Minneapolis (United States), Acquired	Developer of biotech reagents, instruments and clinical diagnostic products	-	HHS	59/100
8th	Abselion 2018, Cambridge (United Kingdom), Series A	Provider of a benchtop instrument for protien research	$12.6M	University of Cambridge, M Ventures & 13 others	59/100
9th	Applied BioCode 2008, Santa Fe Springs (United States), Public	Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications	$20.3M	ID Ventures America, TPTF & 4 others	59/100
10th	Bio Rad 1952, Hercules (United States), Public	Portfolio of products and services for life science research and clinical diagnostic markets	-	Bellevue Healthcare Trust, SMB Capital Partners ... & 3 others	58/100
387th	Elispot Shaker Heights (United States), Unfunded	Manufacturer of laboratory assay systems for detecting immune cell responses	-	-	16/100